Search Results - "MCMASTERS, Daniel R"

Refine Results
  1. 1

    eCounterscreening: Using QSAR Predictions to Prioritize Testing for Off-Target Activities and Setting the Balance between Benefit and Risk by Sheridan, Robert P, McMasters, Daniel R, Voigt, Johannes H, Wildey, Mary Jo

    “…During drug development, compounds are tested against counterscreens, a panel of off-target activities that would be undesirable for a drug to have. Testing…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Use of Density Functional Calculations To Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase by Torres, Rhonda A, Korzekwa, Kenneth R, McMasters, Daniel R, Fandozzi, Christine M, Jones, Jeffrey P

    Published in Journal of medicinal chemistry (20-09-2007)
    “…Aldehyde oxidase is a molybdenum hydroxylase that catalyzes the oxidation of aldehydes and nitrogen-containing heterocycles. The enzyme plays a dual role in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Impact of pH on Plasma Protein Binding in Equilibrium Dialysis by Kochansky, Christopher J, McMasters, Daniel R, Lu, Ping, Koeplinger, Kenneth A, Kerr, Haley H, Shou, Magang, Korzekwa, Kenneth R

    Published in Molecular pharmaceutics (01-05-2008)
    “…Many pharmacokinetic analyses require unbound plasma concentrations, including prediction of clearance, volume of distribution, drug−drug interactions, brain…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Smallest Maximum Intramolecular Distance: A Novel Method to Mitigate Pregnane Xenobiotic Receptor Activation by Bower, Michael J, Aronov, Alex M, Cleveland, Thomas, Hariparsad, Niresh, McGaughey, Georgia B, McMasters, Daniel R, Zhang, Xiaodan, Goldman, Brian

    “…Induction of cytochrome P450 isoform 3A4 via activation of the pregnane xenobiotic receptor (PXR) is a concern for pharmaceutical discovery and development, as…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    QSAR Models for Predicting the Similarity in Binding Profiles for Pairs of Protein Kinases and the Variation of Models between Experimental Data Sets by Sheridan, Robert P, Nam, Kiyean, Maiorov, Vladimir N, McMasters, Daniel R, Cornell, Wendy D

    “…We propose a direct QSAR methodology to predict how similar the inhibitor-binding profiles of two protein kinases are likely to be, based on the properties of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Spiroimidazolidinone NPC1L1 inhibitors. Part 2: Structure–activity studies and in vivo efficacy by Howell, Kobporn L., DeVita, Robert J., Garcia-Calvo, Margarita, Meurer, Roger D., Lisnock, JeanMarie, Bull, Herbert G., McMasters, Daniel R., McCann, Margaret E., Mills, Sander G.

    Published in Bioorganic & medicinal chemistry letters (01-12-2010)
    “…Ezetimibe (Zetia®), a cholesterol-absorption inhibitor (CAI) approved by the FDA for the treatment of hypercholesterolemia, is believed to target the intestine…”
    Get full text
    Journal Article
  18. 18

    Synthesis and HCV inhibitory properties of 9-deaza- and 7,9-dideaza-7-oxa-2′- C-methyladenosine by Butora, Gabor, Olsen, David B., Carroll, Steven S., McMasters, Daniel R., Schmitt, Christoph, Leone, Joseph F., Stahlhut, Mark, Burlein, Christine, MacCoss, Malcolm

    Published in Bioorganic & medicinal chemistry (01-08-2007)
    “…2′- C-Methyl analogs of 7-oxa- and 7-aza-7,9-dideazadenosines were synthesized and their metabolic stability as well as antiviral (HCV) properties evaluated…”
    Get full text
    Journal Article
  19. 19

    Inhibition of Recombinant Cytochrome P450 Isoforms 2D6 and 2C9 by Diverse Drug-like Molecules by McMasters, Daniel R, Torres, Rhonda A, Crathern, Susan J, Dooney, Deborah L, Nachbar, Robert B, Sheridan, Robert P, Korzekwa, Kenneth R

    Published in Journal of medicinal chemistry (12-07-2007)
    “…The affinities of a diverse set of 500 drug-like molecules to cytochrome P450 isoforms 2C9 and 2D6 were measured using recombinant expressed enzyme. The…”
    Get full text
    Journal Article
  20. 20

    Spiroimidazolidinone NPC1L1 inhibitors. 1: Discovery by 3D-similarity-based virtual screening by McMasters, Daniel R., Garcia-Calvo, Margarita, Maiorov, Vladimir, McCann, Margaret E., Meurer, Roger D., Bull, Herbert G., Lisnock, JeanMarie, Howell, Kobporn L., DeVita, Robert J.

    Published in Bioorganic & medicinal chemistry letters (01-06-2009)
    “…A series of spiroimidazolidinone NPC1L1 inhibitors was discovered by virtual screening of the Merck corporate sample repository using 3D-similarity-based…”
    Get full text
    Journal Article